Is Autologous Salvaged Blood a Viable Option for Patient Blood Management in Oncologic Surgery?

Transfusion Medicine Reviews

Volumn 31, Issue 1, 2017, Pages 56-61

  Zaw, Aye Sandar ^a   Bangalore Kantharajanna, Shashidhar ^a   Kumar, Naresh ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Circulating tumor cells; Metastasis; Oncologic surgery; Primary cancer; Salvaged blood; Tumor cells

Indexed keywords

ADVERSE OUTCOME; AUTOLOGOUS SALVAGED BLOOD TRANSFUSION; BLOOD SAMPLING; BLOOD TRANSFUSION; CANCER PATIENT; CANCER SURGERY; CIRCULATING TUMOR CELL; CLINICAL EFFECTIVENESS; HUMAN; METASTASIS; REVIEW; SAFETY; SALVAGE THERAPY; TREATMENT CONTRAINDICATION; TUMOR CELL; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; EVALUATION STUDY; NEOPLASM; PATHOLOGY; PERIOPERATIVE PERIOD; PROCEDURES; TREATMENT OUTCOME; TUMOR EMBOLISM;

BLOOD TRANSFUSION, AUTOLOGOUS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; OPERATIVE BLOOD SALVAGE; PERIOPERATIVE CARE; TREATMENT OUTCOME;

EID: 85002885016     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2016.06.003     Document Type: Review

References (71)

1. [1] Witham, TF, Khavkin, YA, Gallia, GL, Wolinsky, JP, Gokaslan, ZL, Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol 2 (2006), 87–94 [quiz 116].
2. [2] Chen, Y, Tai, BC, Nayak, D, Kumar, N, Lim, JW, Goy, RWL, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Joint J 95-B (2013), 683–688.
3. [3] Kumar, N, Zaw, AS, Khine, HE, Maharajan, K, Wai, KL, Tan, B, et al. Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors. Ann Surg Oncol 23 (2016), 2079–2086.
4. [4] Sixty-third World Health Assembly: WHA63.12, availability, safety and quality of blood products. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf [accessed March 13, 2016].
5. [5] Spahn, DR, Shander, A, Hofmann, A, The chiasm: transfusion practice versus patient blood management. Best Pract Res Clin Anaesthesiol 27 (2013), 37–42.
6. [6] Kumar, N, Chen, Y, Nath, C, Liu, EH, What is the role of autologous blood transfusion in major spine surgery?. Am J Orthop (Belle Mead NJ) 41 (2012), E89–E95.
7. [7] Williamson, KR, Taswell, HF, Intraoperative blood salvage: a review. Transfusion 31 (1991), 662–675.
8. [8] Carless, PA, Henry, DA, Moxey, AJ, O'Connell, D, Brown, T, Fergusson, DA, Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 4, 2010, CD001888.
9. [9] McKenna, SJ, Autologous blood transfusions. Council on Scientific Affairs. JAMA 256 (1986), 2378–2380.
10. [10] Yaw, PB, Sentany, M, Link, WJ, Wahle, WM, Glover, JL, Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery?. JAMA 231 (1975), 490–491.
11. [11] Yamaguchi, K, Takagi, Y, Aoki, S, Futamura, M, Saji, S, Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232 (2000), 58–65.
12. [12] Dale, RF, Kipling, RM, Smith, MF, Collier, DS, Smith, PJ, Separation of malignant cells during autotransfusion. Br J Surg, 75, 1988, 581.
13. [13] Lane, TA, The effect of storage on the metastatic potential of tumor cells collected in autologous blood. An animal model. Transfusion 29 (1989), 418–420.
14. [14] Edelman, MJ, Potter, P, Mahaffey, KG, Frink, R, Leidich, RB, The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology 47 (1996), 179–181.
15. [15] Futamura, N, Nakanishi, H, Hirose, H, Nakamura, S, Tatematsu, M, The effect of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surg 71 (2005), 585–590.
16. [16] Kongsgaard, UE, Wang, MY, Kvalheim, G, Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand 40 (1996), 118–120.
17. [17] Miller, GV, Ramsden, CW, Primrose, JN, Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br J Surg 78 (1991), 713–715.
18. [18] Muller, M, Kuhn, DF, Hinrichs, B, Schindler, E, Dreyer, T, Hirsch, C, et al. Is the elimination of osteosarcoma cells with intraoperative “mesh autotransfusion” and leukocyte depletion filters possible?. Anaesthesist 45 (1996), 834–838.
19. [19] Kumar, N, Chen, Y, Zaw, AS, Nayak, D, Ahmed, Q, Soong, R, et al. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol 15 (2014), e33–e41.
20. [20] Waters, JH, Yazer, M, Chen, YF, Kloke, J, Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 52 (2012), 2167–2173.
21. [21] Catling, S, Williams, S, Freites, O, Rees, M, Davies, C, Hopkins, L, Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 63 (2008), 1332–1338.
22. [22] Perseghin, P, Vigano, M, Rocco, G, Della Pona, C, Buscemi, A, Rizzi, A, Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang 72 (1997), 221–224.
23. [23] Poli, M, Camargo, A, Villa, L, Moura, R, Colella, R, Deheinzelin, D, Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker. Vox Sang 95 (2008), 308–312.
24. [24] Martin, RC, Wellhausen, SR, Moehle, DA, Martin, AW, McMasters, KM, Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol 12 (2005), 1017–1024.
25. [25] Liang, TB, Li, DL, Liang, L, Li, JJ, Bai, XL, Yu, W, et al. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation 85 (2008), 863–869.
26. [26] Kumar, N, Ahmed, Q, Lee, VK, Chen, Y, Zaw, AS, Goy, R, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery?. Ann Surg Oncol 21 (2014), 2436–2443.
27. [27] Kumar, N, Ahmed, Q, Lee, VK, Zaw, AS, Goy, R, Wong, HK, Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery?. Eur Spine J, 2015, 10.1007/s00586-015-4112-x.
28. [28] Allard, WJ, Matera, J, Miller, MC, Repollet, M, Connelly, MC, Rao, C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10 (2004), 6897–6904.
29. [29] Allan, AL, Keeney, M, Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol, 2010, 2010, 426218.
30. [30] Cristofanilli, M, Budd, GT, Ellis, MJ, Stopeck, A, Matera, J, Miller, MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351 (2004), 781–791.
31. [31] Danila, DC, Heller, G, Gignac, GA, Gonzalez-Espinoza, R, Anand, A, Tanaka, E, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 13 (2007), 7053–7058.
32. [32] de Bono, JS, Scher, HI, Montgomery, RB, Parker, C, Miller, MC, Tissing, H, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14 (2008), 6302–6309.
33. [33] Karczewski, DM, Lema, MJ, Glaves, D, The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesth Analg 78 (1994), 1131–1135.
34. [34] Kumar, N, Zaw, AS, Khoo, BL, Nandi, S, Lai, Z, Singh, G, et al. Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells. Eur Spine J, 2016, 10.1007/s00586-016-4478-4.
35. [35] Chambers, AF, Groom, AC, MacDonald, IC, Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 (2002), 563–572.
36. [36] Chambers, AF, Naumov, GN, Varghese, HJ, Nadkarni, KV, MacDonald, IC, Groom, AC, Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 10 (2001), 243–255 [vii].
37. [37] Pantel, K, Brakenhoff, RH, Dissecting the metastatic cascade. Nat Rev Cancer 4 (2004), 448–456.
38. [38] Woodhouse, EC, Chuaqui, RF, Liotta, LA, General mechanisms of metastasis. Cancer 80 (1997), 1529–1537.
39. [39] Bower, MR, Ellis, SF, Scoggins, CR, McMasters, KM, Martin, RC, Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol 18 (2011), 166–173.
40. [40] Connor, JP, Morris, PC, Alagoz, T, Anderson, B, Bottles, K, Buller, RE, Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol 86 (1995), 373–378.
41. [41] Davis, M, Sofer, M, Gomez-Marin, O, Bruck, D, Soloway, MS, The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence?. BJU Int 91 (2003), 474–476.
42. [42] Ford, BS, Sharma, S, Rezaishiraz, H, Huben, RS, Mohler, JL, Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 26 (2008), 364–367.
43. [43] Gorin, MA, Eldefrawy, A, Manoharan, M, Soloway, MS, Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. World J Urol 30 (2012), 379–383.
44. [44] Gray, CL, Amling, CL, Polston, GR, Powell, CR, Kane, CJ, Intraoperative cell salvage in radical retropubic prostatectomy. Urology 58 (2001), 740–745.
45. [45] Kim, JM, Kim, GS, Joh, JW, Suh, KS, Park, JB, Ko, JS, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int 26 (2013), 84–89.
46. [46] Muscari, F, Suc, B, Vigouroux, D, Duffas, JP, Migueres, I, Mathieu, A, et al. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence?. Transpl Int 18 (2005), 1236–1239.
47. [47] Nieder, AM, Carmack, AJ, Sved, PD, Kim, SS, Manoharan, M, Soloway, MS, Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology 65 (2005), 730–734.
48. [48] Nieder, AM, Manoharan, M, Yang, Y, Soloway, MS, Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 69 (2007), 881–884.
49. [49] Park, KI, Kojima, O, Tomoyoshi, T, Intra-operative autotransfusion in radical cystectomy. Br J Urol 79 (1997), 717–721.
50. [50] Stoffel, JT, Topjian, L, Libertino, JA, Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int 96 (2005), 313–315.
51. [51] Klimberg, IW, Autotransfusion and blood conservation in urologic oncology. Semin Surg Oncol 5 (1989), 286–292.
52. [52] Bridgens, JP, Evans, CR, Dobson, PM, Hamer, AJ, Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study. J Bone Joint Surg Am 89 (2007), 270–275.
53. [53] Colwell, CW Jr., Beutler, E, West, C, Hardwick, ME, Morris, BA, Erythrocyte viability in blood salvaged during total joint arthroplasty with cement. J Bone Joint Surg Am 84-A (2002), 23–25.
54. [54] Krajewski, K, Ashley, RK, Pung, N, Wald, S, Lazareff, J, Kawamoto, HK, et al. Successful blood conservation during craniosynostotic correction with dual therapy using procrit and cell saver. J Craniofac Surg 19 (2008), 101–105.
55. [55] Salaria, ON, Barodka, VM, Hogue, CW, Berkowitz, DE, Ness, PM, Wasey, JO, et al. Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg 118 (2014), 1179–1187.
56. [56] Innerhofer, P, Klingler, A, Klimmer, C, Fries, D, Nussbaumer, W, Risk for postoperative infection after transfusion of white blood cell–filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 45 (2005), 103–110.
57. [57] Foltys, D, Zimmermann, T, Heise, M, Kaths, M, Lautem, A, Wisser, G, et al. Liver transplantation for hepatocellular carcinoma—is there a risk of recurrence caused by intraoperative blood salvage autotransfusion?. Eur Surg Res 47 (2011), 182–187.
58. [58] Hirano, T, Yamanaka, J, Iimuro, Y, Fujimoto, J, Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today 35 (2005), 1042–1046.
59. [59] Yazer, MH, Triulzi, DJ, Things aren't always as they seem: what the randomized trials of red blood cell transfusion tell us about adverse outcomes. Transfusion 54 (2014), 3243–3246 [quiz 3242].
60. [60] Ashworth, A, Klein, AA, Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 105 (2010), 401–416.
61. [61] Dzik, WH, Sherburne, B, Intraoperative blood salvage: medical controversies. Transfus Med Rev 4 (1990), 208–235.
62. [62] Esper, SA, Waters, JH, Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 9 (2011), 139–147.
63. [63] Waters, JH, Intraoperative blood recovery. ASAIO J 59 (2013), 11–17.
64. [64] Mirhashemi, R, Averette, HE, Deepika, K, Estape, R, Angioli, R, Martin, J, et al. The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol 181 (1999), 1310–1315 [discussion 1315–1316].
65. [65] Fujimoto, J, Okamoto, E, Yamanaka, N, Oriyama, T, Furukawa, K, Kawamura, E, et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg 128 (1993), 1065–1069.
66. [66] Akbulut, S, Kayaalp, C, Yilmaz, M, Ince, V, Ozgor, D, Karabulut, K, et al. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol 19 (2013), 1625–1631.
67. [67] Han, S, Kim, G, Ko, JS, Sinn, DH, Yang, JD, Joh, JW, et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg, 2015, 10.1097/SLA.0000000000001486.
68. [68] Araujo, RL, Pantanali, CA, Haddad, L, Rocha Filho, JA, D'Albuquerque, LA, Andraus, W, Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?. World J Gastrointest Surg 8 (2016), 161–168.
69. [69] Ubee, S, Kumar, M, Athmanathan, N, Singh, G, Vesey, S, Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost–benefit analysis. Ann R Coll Surg Engl 93 (2011), 157–161.
70. [70] Raval, JS, Nelson, JB, Woldemichael, E, Triulzi, DJ, Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. Transfusion 52 (2012), 2590–2593.
71. [71] Gakhar, H, Bagouri, M, Bommireddy, R, Klezl, Z, Role of intraoperative red cell salvage and autologus transfusion in metastatic spine surgery: a pilot study and review of literature. Asian Spine J 7 (2013), 167–172.